Parameters | Drug treatment (N = 16, 27 knees) | No drug treatment (N = 11, 17 knees) | p value |
---|---|---|---|
Agea, year | 39.56 ± 11.74 | 38.64±9.21 | 0.828 |
Gender | |||
Male, no. (%) | 8 (50%) | 7(63.63%) | 0.696 |
Female, no.(%) | 8 (50%) | 4(36.36%) | |
Heighta, cm | 163.94 ± 12.15 | 162.82±8.32 | 0.793 |
Weighta, kg | 62.29 ± 15.61 | 54.00±8.34 | 0.121 |
BMIa, kg/m2 | 22.97 ± 4.15 | 20.44±3.25 | 0.102 |
Diagnosis | 1.000 | ||
Rheumatoid arthritis | 9 | 7 | |
Ankylosing spondylitis | 7 | 4 | |
Knee | |||
Left knee | 13 | 10 | 0.548 |
Right knee | 14 | 7 | |
Bilateral TKAs | 11 | 6 | |
Unilateral TKA | 5 | 5 | |
Inpatient daysb, days | 13.5 (6–29) | 12 (7–28) | 0.568 |
Follow-upb, months | 46.5 (35–69) | 58 (34–69) | 0.138 |
Crutch, no. (%) | |||
With crutch | 7 (43.75%) | 2 (18.18%) | 0.231 |
Without crutch | 9 (56.25%) | 9 (81.82%) | |
Revision knee, no. (%) | 2 (2/44, 2.27%) | 0 | 1.000 |